International Journal of Drug Delivery Technology
Volume 14, Issue 3

Microneedle Transdermal Patches- A Novel Painless Approach with Improved Bioavailability for the Treatment of Diseases with Special Prevalence to Neonatal Infections

Gaurav Pundir1, Srishti Morris1*, Vikash Jakhmola1, Tarun Parashar2

1Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Premnagar, Dehradun, Uttarakhand, India.

2School of Pharmacy & Research, Dev Bhoomi Uttarakhand University, Dehradun, Uttarakhand, India.

Received: 23rd May, 2024; Revised: 02nd June, 2024; Accepted: 27th June, 2024; Available Online: 25th September, 2024 

ABSTRACT

Microneedle transdermal drug delivery systems (TDDS) present a compelling substitute for parenteral and oral administration methods in the treatment of several illnesses. The past several decades have seen a revolution in technology that has changed the production of micro-structured devices, including the development of microneedles for transdermal patches. These devices are used to deliver drugs, proteins, insulin, antibiotics, vaccinations, and other therapies through the skin. They are proven to be beneficial for the prevention of newborn infections. Successful treatments for conditions like cancer, diabetes, rheumatoid arthritis, Alzheimer’s disease, and migraines can be achieved with the use of transdermal microneedle patches. Microneedles have the potential to offer prolonged immunity, dosage sparing, and improved protection against viral challenges. The epidermis and dermis are immunologically rich layers, and because of the needles’ micron-size structure, these devices have shown to be significantly more effective at targeting these layers, indicating their potential utility in the creation of next-generation vaccines. Within the framework of developing vaccines. Microneedle transdermal patches’ main benefits are that they are easy to use, painless, and non-invasive. Here, we discuss the types of microneedle transdermal patches and how microneedle transdermal patches are now being used to treat infections in newborns and vaccination and as a more cost-effective self-administration approach. This also enhances the bioavailability when used in vaccination therapy. Next, we’ll go over how microneedle transdermal patches are currently used to treat a variety of illnesses effectively, including those that affect newborns.

Keywords: Transdermal, Microneedles, Bioavailability, Rheumatoid arthritis. International Journal of Drug Delivery Technology (2024); DOI: 10.25258/ijddt.14.3.71

How to cite this article: Pundir G, Morris S, Jakhmola V, Parashar T. Microneedle Transdermal Patches- A Novel Painless Approach with Improved Bioavailability for the Treatment of Diseases with Special Prevalence to Neonatal Infections. International Journal of Drug Delivery Technology. 2024;14(3):1749-1757.

REFERENCES

  1. Mdanda S, Ubanako P, Kondiah PPD,,2021 Recent advances in microneedle platforms for transdermal drug delivery Polymers (Basel).;13(15). doi:10.3390/polym13152405
  2. Wong WF, Ang KP, Sethi G, et al, 2023. Recent Advancement of Medical Patch for Transdermal Drug Delivery. Medicina (Lithuania);59(4). doi:10.3390/medicina59040778
  3. Jeong WY, Kwon M, Choi HE, et al 2021, Recent advances in transdermal drug delivery systems: a Biomater Res. 25(1). doi:10.1186/S40824-021-00226-6
  4. Bird D, Ravindra NM, 2020, Transdermal drug delivery and patches—An overview. Med Devices Sens. 3(6). doi:10.1002/ 10069
  5. Grammatikopoulou MG, Gkiouras K, Dardiotis E, et al 2021, Peeking into the future: Transdermal patches for the delivery of micronutrient supplements. Metabol Open. 11:100109. doi:10.1016/j.metop.2021.100109
  6. Rad ZF, Prewett PD, Davies GJ,2021, An overview of microneedle applications, materials, and fabrication methods. Beilstein Journal of Nanotechnology.12:1034-1046. doi:10.3762/ BJNANO.12.77
  7. Nazary Abrbekoh F, Salimi L, Saghati S, et al,2022, application of microneedle patches for drug delivery; doorstep to novel therapies. J Tissue Eng. 13. doi:10.1177/20417314221085390
  8. Wong WF, Ang KP, Sethi G, et al,2023, Recent Advancement of Medical Patch for Transdermal Drug Delivery. Medicina (Lithuania). 59(4). doi:10.3390/medicina59040778
  9. Pastore MN, Kalia YN, Horstmann M, et al,2015 Transdermal patches: History, development and Br J Pharmacol. 2015;172(9):2179-2209. doi:10.1111/BPH.13059
  10. Grammatikopoulou MG, Gkiouras K, Dardiotis E, et al,2021. Peeking into the future: Transdermal patches for the delivery of micronutrient supplements. Metabol Open. 11:100109. doi:10.1016/J.METOP.2021.100109
  11. Patil PM, Chaudhari PD, Patel JK, et al,2012 Recent Trends in Challenges and Opportunities of Transdermal Drug Delivery System “Recent Trends in Challenges and Opportunities of Transdermal Drug Delivery ” Vol 4. http://www.ijddr.in
  12. Ho HN, Le TG, Dao TTT, et al, 2020 Development of Itraconazole- Loaded Polymeric Nanoparticle Dermal Gel for Enhanced Antifungal Efficacy. J Nanomater.. doi:10.1155/2020/8894541
  13. Zhang Y, Yu J, Wang J, et al ,2017 Thrombin-Responsive Transcutaneous Patch for Auto-Anticoagulant Regulation. Advanced Materials. 29(4). doi:10.1002/adma.201604043
  14. Kumar A, Sawant , 2013 Solid lipid nanoparticle- incorporated gel: the future treatment for skin infections? Nanomedicine. 8(12):1901-1903. doi:10.2217/nnm.13.171
  15. Baroli B, 2010 Penetration of nanoparticles and nanomaterials in the skin: Fiction or reality? J Pharm Sci.;99(1):21-50. doi:10.1002/ 21817
  16. Prausnitz MR, Langer , 2008, Transdermal drug delivery. Nat Biotechnol. 26(11):1261-1268. doi:10.1038/nbt.1504
  17. Ita K, 2015 Transdermal delivery of drugs with microneedles— potential and Pharmaceutics.;7(3):90-105. doi:10.3390/ pharmaceutics7030090
  18. Silalahi AA, Sinaga KR, Sumaiyah S.,2018,Formulation and evaluation of ketoprofen transdermal matrix patch containing different polymer Asian Journal of Pharmaceutical and Clinical Research. 2018;11(11):316-318. doi:10.22159/ ajpcr.2018.v11i11.27282
  19. Waghule T, Singhvi G, Dubey SK, et al,2019, Microneedles: A smart approach and increasing potential for transdermal drug delivery system. Biomedicine and Pharmacotherapy.;109:1249-1258. doi:10.1016/j.biopha.2018.10.078
  20. Bodkhe SN, Kale RH, Biyani KR,2020, A Review of Microneedles-Elevation to TDDS Approach and Function in Management of Psoriasis. Asian Journal of Pharmaceutical Research and Development. 2020;8(4):114-122. doi:10.22270/ajprd.v8i5.830
  21. Kala S, Bathyal GS, Juyal D,2018, Formulation and Evaluation of Ketoconazole Loaded Transdermal Gel using Natural Penetration Int J Chemtech Res.;11(11):309-314. doi:10.20902/ ijctr.2018.111133
  22. Rasheed, H., Tirumoorthy, N., & Kundlik, G.,2007, Enhanced transdermal delivery of ketoconazole via ethosomes formulation and evaluation. World J Pharm Pharm Sci, 1(1), 238-49.
  23. Adhikari BB, Goodson JL, Chu SY, Rota PA, Meltzer MI. Assessing the Potential Cost-Effectiveness of Microneedle Patches in Childhood Measles Vaccination Programs: The Case for Further Research and Development. Drugs in R and D. 2016;16(4):327-338. doi:10.1007/s40268-016-0144-x
  24. Rangari AT,2015, Polymeric Nanoparticles Based Topical Drug Delivery: An Overview. Asian Journal of Biomedical and Pharmaceutical Sciences.05(47):05-12. doi:10.15272/ajbps. 718
  25. Phatak A, Phatak AA*, Praveen C, 2012,Development and Evaluation of Nanogel as a Carrier for Transdermal Delivery of Aceclofenac NANOTECHNOLOGY BASED DELIVERY View Project Development and Evaluation of Nanogel as a Carrier for Transdermal Delivery of Aceclofenac. Vol 2.; https:// researchgate.net/publication/235606352
  26. Demir YK, Akan Z, Kerimoglu O, 2013, Characterization of Polymeric Microneedle Arrays for Transdermal Drug Delivery. PLoS One. 8(10). doi:10.1371/journal.pone.0077289
  27. Parhi R, Padilam S, 2018, In vitro permeation and stability studies on developed drug-in-adhesive transdermal patch of Bulletin of Faculty of Pharmacy, Cairo University.;56(1):26-33. doi:10.1016/j.bfopcu.2018.04.001
  28. Bariya SH, Gohel MC, Mehta TA, et al, 2012. Microneedles: An emerging transdermal drug delivery system. Journal of Pharmacy and Pharmacology. 64(1):11-29. doi:10.1111/j.2042- 2011.01369.x
  29. Jalwal, , Jangra, A., Dahiya, L., et al, 2010, A review ontransdermal patches. The Pharma Research, 3, 139-149.
  30. Chu LY, Ye L, Dong K, et al,2016 Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Pharm Res. 2016;33(4):868-878. doi:10.1007/s11095-015-1833-9
  31. Joshi N, Azizi Machekposhti S, Narayan RJ,2023, Evolution of Transdermal Drug Delivery Devices and Novel Microneedle Technologies: A Historical Perspective and JID Innov. 3(6):100225. doi:10.1016/j.xjidi.2023.100225
  32. Ahmed Saeed AL,Japairai K, Mahmood S, et al, 2020, Current trends in polymer microneedle for transdermal drug delivery. Int J Pharm. 2020;587:119673. doi:10.1016/J.IJPHARM.119673
  33. Vallhov H, Xia W, Engqvist H, et al, 2018, Bioceramic microneedle arrays are able to deliver OVA to dendritic cells in human J Mater Chem B. 6(42):6808-6816. doi:10.1039/ C8TB01476K
  34. Zhang W, Zhang W, Li C, et al,2022, Recent Advances of Microneedles and Their Application in Disease Treatment. International Journal of Molecular Sciences 2022, Vol 23, Page 2401. (5):2401. doi:10.3390/IJMS23052401
  35. Modi P, 2007, Diabetes Beyond Insulin: Review of New Drugs for Treatment of Diabetes Mellitus. Curr Drug Discov Technol.;4(1):39-47. doi:10.2174/157016307781115476
  36. Zhang Y, Liu Q, Yu J, et al,2017. Locally Induced AdiposeTissue Browning by Microneedle Patch for Obesity Treatment.ACS Nano.;11(9):9223-9230. doi:10.1021/ACSNANO.7B04348/SUPPL_FILE/NN7B04348_SI_001.PDF
  37. Yan Q, Wang W, Weng J, et al,2020, Dissolving microneedles for transdermal delivery of huperzine A for the treatment of Alzheimer’s disease. Drug Deliv.;27(1):1147-1155. doi:10.1080/ 10717544.2020.1797240
  38. Rapoport AM, Ameri M, Lewis H, et al,.2020, development of a novel zolmitriptan intracutaneous microneedle system (QtryptaTM) for the acute treatment of migraine. https://doi. org/102217/pmt-2020-0041. 2020;10(6):359-366. doi:10.2217/ PMT--0041
  39. Ornelas J, Foolad N, Shi V, et al,. 2016, Effect of Microneedle Pretreatment on Topical Anesthesia: A Randomized Clinical Trial. JAMA Dermatol.;152(4):476-477. doi:10.1001/ 2015.5544
  40. Zhao ZQ, Zhang BL, Chu HQ, et al,2022, A high-dosage microneedle for programmable lidocaine delivery and enhanced local long-lasting Biomaterials Advances.;133:112620. doi:10.1016/J.MSEC.2021.112620
  41. González-Vázquez P, Larrañeta E, McCrudden MTC, et al, 2017 Transdermal delivery of gentamicin using dissolving microneedle arrays for potential treatment of neonatal sepsis. Journal of Controlled Release. 217;265:30-40. doi:10.1016/J. 2017.07.032
  42. Mansour A, Romani M, Acharya AB, et al,2023,. Drug Delivery Systems in Regenerative Medicine: An Updated Review. Pharmaceutics.;15(2). doi:10.3390/PHARMACEUTICS15020695
  43. Choi YH, Perez-Cuevas MB, Kodani M, et al, 2019, Feasibility of Hepatitis B Vaccination by Microneedle Patch: Cellular and Humoral Immunity Studies in Rhesus Macaques. J Infect Dis.;220(12):1926-1934. doi:10.1093/INFDIS/JIZ399
  44. Oh YJ, Cha HR, Hwang SJ, et al, 2021, Ovalbumin and cholera toxin delivery to buccal mucus for immunization using microneedles and comparison of immunological response to transmucosal delivery. Drug Deliv Transl Res.;11(4):1390-1400. doi:10.1007/S13346-021-00964-Z/METRICS
  45. Ismail ESA, Patsatsi A, Abd el-Maged WM, et al, 2019, efficacy of microneedling with topical vitamin C in the treatment of melasma. J Cosmet Dermatol. 18(5):1342-1347. doi:10.1111/ 12878
  46. Azukizawa H, Hirobe S, Hanafusa T, et al.,2013, A Clinical study of influenza vaccine using a dissolving microneedle J Dermatol Sci.;69(2):e33. doi:10.1016/j.jdermsci.2012.11.399
  47. Groot AM de, Anouk AC, Kuijt N, et al, 2017, Nanoporous microneedle arrays effectively induce antibody responses against diphtheria and tetanus Front Immunol. 2017;8(DEC):309185. doi:10.3389/FIMMU.2017.01789/BIBTEX
  48. El-Housiny S, Eldeen MAS, El-Attar YA, et al, 2018, Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: Formulation and clinical Drug Deliv. 25(1):78-90. doi:10.1080/10717544.2017.1413444
  49. Andrews SN, Jeong E, Prausnitz MR,2013, Transdermal delivery of molecules is limited by full epidermis, not just stratum corneum. Pharm Res.;30(4):1099-1109. doi:10.1007/S11095- 012-0946-7
  50. Zhu L, Li Y, Gong L, Chen X, et al, 2019, Coupled investigation on drag reduction and thermal protection mechanism induced by a novel combinational spike and multi-jet strategy in hypersonic f Int J Heat Mass Transf.;131:944-964. doi:10.1016/j. ijheatmasstransfer.2018.11.119
  51. Levin Y, Kochba E, Hung I, et al, 2015,. Intradermal vaccination using the novel microneedle device MicronJet600: Past, present, and Hum Vaccin Immunother.;11(4):991-997. doi:10.1080/21645515.2015.1010871
  52. Alkilani AZ, Mc Cr udden MTC, Donnelly R F, 2015 Transdermal drug delivery: Innovative pharmaceuticaldevelopments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics.;7(4):438-470. doi:10.3390/ PHARMACEUTICS7040438
  53. Nguyen HX, Nguyen CN, 2023 Microneedle-Mediated Tr a n s d e r m al D e l i v e r y o f B i o p h a r m a c e u t i c als . Pharmaceutics.;15(1). doi:10.3390/PHARMACEUTICS15010277